How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,046 results for


Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

values that in the opinion of the primary surgeon would prevent surgical resection Subjects receiving class IA (quinidine, procainamide) or class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents Subjects with a history or evidence of interstitial pneumonitis or pulmonary fibrosis Subjects not deemed to be appropriate candidates for optimal resection of tumor based on location, involvement of eloquent brain, satellite lesions, or other factors not specifically listed here Contacts

2018 Clinical Trials

122. Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head and Neck Cancer

within 6 months prior to enrollment History of infusion reactions monoclonal antibody therapies Pregnant or breastfeeding Magnesium or potassium lower than the normal institutional values Patients receiving class IA (quinidine, procainamide) or class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents Patients with a history or evidence of interstitial pneumonitis or pulmonary fibrosis Hypersensitivity to dextran and/or modified form thereof Contacts and Locations Go to Information from

2018 Clinical Trials

123. Effects of Metformin During Nicotine Withdrawal

otherwise by the Study PI or Study Physician, upon review. Medication: Current use or recent discontinuation (within the past 14 days) of any of the following medications: Anti-anxiety or panic disorder medications (e.g., clonazepam, alprazolam). Anti-psychotic medications as assessed on a case-by-case basis Glucophage/metformin Glyburide Furosemide or digoxin Nifedipine Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim

2018 Clinical Trials

124. Management of Supraventricular Tachycardia of Children

at some point. While in most cases ventricular tachycardia can be considered a benign rhythm disorder, special consideration needs to be given to infants, athletes and patients with Wolff-Parkinson-White syndrome. Condition or disease Intervention/treatment Supraventricular Tachycardia Drug: adenosine,Propranolol,flecainide, amiodarone, propranolol, digoxin and procainamide. Study Design Go to Layout table for study information Study Type : Observational [Patient Registry] Estimated Enrollment : 50 (...) and Cohorts Go to Intervention Details: Drug: adenosine,Propranolol,flecainide, amiodarone, propranolol, digoxin and procainamide. drugs used for treatment of supraventricular tachycardia Outcome Measures Go to Primary Outcome Measures : Evaluate management of SVT in the cardiology unit of Assiut University Children Hospital according to international guidelines by using pharmacological and non pharmacological treatments. [ Time Frame: one year ] Descriptive sheet of the study checklist that will be asked

2018 Clinical Trials

125. Pilot Randomized Trial With Flecainide in ARVC Patients

contraindication to beta-blockers exists. Persons prescribed quinidine, procainamide, propafenone, disopyramide, dronedarone phenytoin, mexilitene, flecainide, may be included after 5 day washout period with subsequent 24 Hour Holter obtained after washout period. Persons prescribed sotalol must be included after 5 day washout period during which another beta-blocker may be administered with subsequent 24 Hour Holter obtained. Subject and personal physician and or cardiologist must agree not to use any

2018 Clinical Trials

126. Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study

to study entry Treatment or planned treatment involving diuretics No current or planned treatment with cationic drugs excreted by the kidneys (e.g. amiloride, cimetidine, digoxin, morphine, nifedipine, procainamide, quinidine, quinine, ranitidine, triamterence, trimethoprim and vancomycin). No treatment or planned treatment with concomitant medications with potential unacceptable interaction with metformin including topirimate, lamotrigine, levetiracetam, beta blockers, ACE inhibitors, glycopyrrolate

2018 Clinical Trials

127. Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

informed consent/assent for the trial. Life expectancy ≥ 12 weeks Willingness to discontinue medications known to be associated with risk of Torsades de Pointes such as quinidine, procainamide, disopyramide, amiodarone, erythromycin, clarithromycin, chlorpromazine and haloperidol Single measureable lesion < 4 cm in longest diameter Patient shouldn't have received any anti-cancer therapy for glioblastoma in past Females of childbearing potential (FOCBP) should have a negative urine or serum pregnancy

2018 Clinical Trials

128. Marijuana Induced Type I Brugada Pattern: A Case Report (PubMed)

. We here present an interesting case of Type I Brugada pattern in electrocardiography (ECG) in a 36 year old healthy African American male who presented after smoking four joints. Urine toxicology test proved marijuana use. Acute coronary syndrome was ruled out, coronary angiogram revealed normal coronaries, 2D echocardiogram showed no evidence of structural heart disease. Upon resolution of Brugada pattern in ECG, procainamide challenge performed in electrophysiology laboratory did not induce

Full Text available with Trip Pro

2018 American journal of medical case reports

129. Amiodarone for sustained stable ventricular tachycardia in the prehospital setting. (PubMed)

for cardioversion occurring very infrequently. Amiodarone was relatively safe and moderately effective for the treatment of sustained stable VT. However, given recent evidence of increased efficacy of procainamide for stable VT, further studies are required in the prehospital setting to compare these two drugs.© 2018 Australasian College for Emergency Medicine and Australasian Society for Emergency Medicine.

2018 Emergency medicine Australasia

130. Contraindicated drug-drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care setting in the United States. (PubMed)

combination was use of fluoroquinolones with antiarrhythmic agents (amiodarone, sotalol, quinidine or procainamide) (365 622 visits, proportion = 0.19%; 95% CI, 0.06-0.32).Providers should be aware of potential contraindicated DDIs when prescribing antibiotics, especially macrolides and fluoroquinolones.Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. All rights reserved.

2018 Clinical Microbiology and Infection

131. Drug-induced lupus: Traditional and new concepts. (PubMed)

Drug-induced lupus: Traditional and new concepts. Drug-induced lupus (DIL) includes a spectrum of drug-induced reactions often characterised by a clinical phenotype similar to that of idiopathic systemic lupus eruthematosus (SLE) but usually lacking major SLE complications. Different drugs may be associated with distinct clinical and serological profiles, and early recognition is crucial. Drugs traditionally associated with DIL include procainamide, hydralazine, quinidine and others, but strong

2018 Autoimmunity reviews

132. A 66-Year-Old Female with Apical Hypertrophic Cardiomyopathy Presenting with Hypertensive Crises and Type 2 Myocardial Infarction and a Normal Coronary Angiogram (PubMed)

) in which the hypertrophy predominantly involves the apex of the left ventricle resulting in midventricular obstruction, as opposed to the left ventricular outflow tract obstruction seen in HCM. Patients with apical HCM may present with angina, heart failure, myocardial infarction, syncope, or arrhythmias and are typically managed with medications like verapamil and beta-blockers for those who have symptoms and antiarrhythmic agents like amiodarone and procainamide for treatment of atrial fibrillation

Full Text available with Trip Pro

2018 Case reports in cardiology

133. Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

drug within 30 days prior to first dose of panitumumab-IRDye800. Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); significant liver disease; or unstable angina within 6 months prior to enrollment. Previous bilateral neck dissection. History of infusion reactions to monoclonal antibody therapies. Pregnant or breastfeeding. Magnesium or potassium lower than the normal institutional values. Subjects receiving class IA (quinidine, procainamide

2018 Clinical Trials

138. Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer

with strong CYP 3A4 inhibitors within the previous two weeks (ketoconazole, clarithromycin, itraconazole, nefazodone, telithromycin) Patients on drugs that may prolong the PR or QRS interval durations, such as any of the Class I/Sodium (Na+) Channel blocking antiarrhythmic medications should be avoided (e.g. Flecainide, Procainamide, Propafenone, Quinidine). Patients with untreated clinically relevant hypothyroidism Patients currently on investigational therapies will be evaluated by the PI on a case

2017 Clinical Trials

139. Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study

that influence DNA methylation: hydralazine, procainamide, methotrexate, valproic acid, tamoxifen, raloxifene, letrozole, anastrozole (Arimidex), or exemestane (Aromasin) Any history of urinary tract malignancy (bladder, urethra, ureter, kidney) Intradetrusor Botox injection within the prior 12 months Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided

2017 Clinical Trials

140. Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair

and Scopolamine, Antiarrhythmics, Amiodarone, Disopyramide, Dofetilide, Procainamide, Quinidine and Sotalol. Anticonvulsants; Carbamazepine, Phenobarbital, Phenytoin and Rifampin) History of previous surgeries in shoulder treated with RAMR Previous neuromuscular deficit Febrile Syndrome Autoimmune or Rheumatologic Disease History of intestinal transit disorders (paralytic ileus) History of alcohol or drug abuse Patients in psychological or psychiatric treatment for anxiety disorders, personality disorders

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>